Évaluation de la pertinence de la prescription des antiparkinsoniens chez l'adulte schizophrène, quelle évolution depuis 2007 ?

An identical methodology has led to comparable results, but the weakness of the samples is still the same, as well as the non-exhaustivity of the population studied.